<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000413946"><TermName>forodesine</TermName><TermPronunciation>(FOR-oh-deh-seen)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of some types of leukemia and lymphoma. It is a type of purine nucleoside phosphorylase (PNP) inhibitor. Also called BCX-1777 and forodesine hydrochloride.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000713521" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;forodesine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000713522" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;forodesina&quot;" language="es" id="_4"/><SpanishTermName>forodesina</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de leucemia y linfoma. Es un tipo de inhibidor de la enzima purina-nucleósido fosforilasa (PNP). También se llama BCX-1777 y hidrocloruro de forodesina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2005-05-23</DateFirstPublished><DateLastModified>2007-06-19</DateLastModified></GlossaryTerm>
